199 related articles for article (PubMed ID: 22787561)
21. Tocilizumab attenuates inflammation in ALS patients through inhibition of IL6 receptor signaling.
Mizwicki MT; Fiala M; Magpantay L; Aziz N; Sayre J; Liu G; Siani A; Chan D; Martinez-Maza O; Chattopadhyay M; La Cava A
Am J Neurodegener Dis; 2012; 1(3):305-15. PubMed ID: 23383400
[TBL] [Abstract][Full Text] [Related]
22. Erythropoietin modulates the immune-inflammatory response of a SOD1(G93A) transgenic mouse model of amyotrophic lateral sclerosis (ALS).
Noh MY; Cho KA; Kim H; Kim SM; Kim SH
Neurosci Lett; 2014 Jun; 574():53-8. PubMed ID: 24820540
[TBL] [Abstract][Full Text] [Related]
23. Resolvin D1 and D2 reduce SARS-CoV-2-induced inflammatory responses in cystic fibrosis macrophages.
Recchiuti A; Patruno S; Mattoscio D; Isopi E; Pomilio A; Lamolinara A; Iezzi M; Pecce R; Romano M
FASEB J; 2021 Apr; 35(4):e21441. PubMed ID: 33749902
[TBL] [Abstract][Full Text] [Related]
24. Effects of resolvin D1 on inflammatory responses and oxidative stress of lipopolysaccharide-induced acute lung injury in mice.
Wang L; Yuan R; Yao C; Wu Q; Christelle M; Xie W; Zhang X; Sun W; Wang H; Yao S
Chin Med J (Engl); 2014; 127(5):803-9. PubMed ID: 24571866
[TBL] [Abstract][Full Text] [Related]
25. Resolvin D1-mediated NOX2 inactivation rescues macrophages undertaking efferocytosis from oxidative stress-induced apoptosis.
Lee HN; Surh YJ
Biochem Pharmacol; 2013 Sep; 86(6):759-69. PubMed ID: 23856291
[TBL] [Abstract][Full Text] [Related]
26. Immunoresolving actions of oral resolvin D1 include selective regulation of the transcription machinery in resolution-phase mouse macrophages.
Recchiuti A; Codagnone M; Pierdomenico AM; Rossi C; Mari VC; Cianci E; Simiele F; Gatta V; Romano M
FASEB J; 2014 Jul; 28(7):3090-102. PubMed ID: 24692596
[TBL] [Abstract][Full Text] [Related]
27. In vitro and in vivo assessment of the proresolutive and antiresorptive actions of resolvin D1: relevance to arthritis.
Benabdoun HA; Kulbay M; Rondon EP; Vallières F; Shi Q; Fernandes J; Fahmi H; Benderdour M
Arthritis Res Ther; 2019 Mar; 21(1):72. PubMed ID: 30867044
[TBL] [Abstract][Full Text] [Related]
28. Resolvin D2 is a potent endogenous inhibitor for transient receptor potential subtype V1/A1, inflammatory pain, and spinal cord synaptic plasticity in mice: distinct roles of resolvin D1, D2, and E1.
Park CK; Xu ZZ; Liu T; Lü N; Serhan CN; Ji RR
J Neurosci; 2011 Dec; 31(50):18433-8. PubMed ID: 22171045
[TBL] [Abstract][Full Text] [Related]
29. Activation transcription factor-3 activation and the development of spinal cord degeneration in a rat model of amyotrophic lateral sclerosis.
Malaspina A; Ngoh SF; Ward RE; Hall JC; Tai FW; Yip PK; Jones C; Jokic N; Averill SA; Michael-Titus AT; Priestley JV
Neuroscience; 2010 Aug; 169(2):812-27. PubMed ID: 20470869
[TBL] [Abstract][Full Text] [Related]
30. Lenalidomide (Revlimid) administration at symptom onset is neuroprotective in a mouse model of amyotrophic lateral sclerosis.
Neymotin A; Petri S; Calingasan NY; Wille E; Schafer P; Stewart C; Hensley K; Beal MF; Kiaei M
Exp Neurol; 2009 Nov; 220(1):191-7. PubMed ID: 19733563
[TBL] [Abstract][Full Text] [Related]
31. Resolvin D1 and its precursor docosahexaenoic acid promote resolution of adipose tissue inflammation by eliciting macrophage polarization toward an M2-like phenotype.
Titos E; Rius B; González-Périz A; López-Vicario C; Morán-Salvador E; Martínez-Clemente M; Arroyo V; Clària J
J Immunol; 2011 Nov; 187(10):5408-18. PubMed ID: 22013115
[TBL] [Abstract][Full Text] [Related]
32. Up-regulated inflammatory signatures of the spinal cord in canine degenerative myelopathy.
Hashimoto K; Kobatake Y; Asahina R; Yamato O; Islam MS; Sakai H; Nishida H; Maeda S; Kamishina H
Res Vet Sci; 2021 Mar; 135():442-449. PubMed ID: 33187678
[TBL] [Abstract][Full Text] [Related]
33. Inhibitory effects of aspirin-triggered resolvin D1 on spinal nociceptive processing in rat pain models.
Meesawatsom P; Burston J; Hathway G; Bennett A; Chapman V
J Neuroinflammation; 2016 Sep; 13(1):233. PubMed ID: 27589850
[TBL] [Abstract][Full Text] [Related]
34. NLRP3 inflammasome is expressed by astrocytes in the SOD1 mouse model of ALS and in human sporadic ALS patients.
Johann S; Heitzer M; Kanagaratnam M; Goswami A; Rizo T; Weis J; Troost D; Beyer C
Glia; 2015 Dec; 63(12):2260-73. PubMed ID: 26200799
[TBL] [Abstract][Full Text] [Related]
35. Regulation of the inflammatory response by vascular grafts modified with Aspirin-Triggered Resolvin D1 promotes blood vessel regeneration.
Shi J; Zhang X; Jiang L; Zhang L; Dong Y; Midgley AC; Kong D; Wang S
Acta Biomater; 2019 Oct; 97():360-373. PubMed ID: 31351251
[TBL] [Abstract][Full Text] [Related]
36. Effects of aspirin-triggered resolvin D1 on peripheral blood mononuclear cells from patients with Chagas' heart disease.
Ogata H; Teixeira MM; Sousa RC; Silva MV; Correia D; Rodrigues Junior V; Levy BD; Rogério Ade P
Eur J Pharmacol; 2016 Apr; 777():26-32. PubMed ID: 26927755
[TBL] [Abstract][Full Text] [Related]
37. The anti-inflammatory and pro-resolution effects of aspirin-triggered RvD1 (AT-RvD1) on peripheral blood mononuclear cells from patients with severe asthma.
Zambalde ÉP; Teixeira MM; Favarin DC; de Oliveira JR; Magalhães ML; Cunha MM; Silva WC; Okuma CH; Rodrigues V; Levy BD; Rogerio AP
Int Immunopharmacol; 2016 Jun; 35():142-148. PubMed ID: 27044027
[TBL] [Abstract][Full Text] [Related]
38. Resolvin D1 Decreases Severity of Streptozotocin-Induced Type 1 Diabetes Mellitus by Enhancing BDNF Levels, Reducing Oxidative Stress, and Suppressing Inflammation.
Bathina S; Das UN
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33546300
[TBL] [Abstract][Full Text] [Related]
39. Signaling and Immunoresolving Actions of Resolvin D1 in Inflamed Human Visceral Adipose Tissue.
Titos E; Rius B; López-Vicario C; Alcaraz-Quiles J; García-Alonso V; Lopategi A; Dalli J; Lozano JJ; Arroyo V; Delgado S; Serhan CN; Clària J
J Immunol; 2016 Oct; 197(8):3360-3370. PubMed ID: 27647830
[TBL] [Abstract][Full Text] [Related]
40. Resolvin D1, resolvin D2 and maresin 1 activate the GSK3β anti-inflammatory axis in TLR4-engaged human monocytes.
Gu Z; Lamont GJ; Lamont RJ; Uriarte SM; Wang H; Scott DA
Innate Immun; 2016 Apr; 22(3):186-95. PubMed ID: 26878867
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
